scorecardresearch
Monday, September 22, 2025
TopicCovishield

Topic: Covishield

Not allowing Covishield, Covaxin retail sale meaningless. Indians need vaccines and boosters

ThePrint view on the most important issues, instantly.

Covishield shows increased antibody response to Omicron after 3rd dose: AstraZeneca

Preliminary data released by AstraZeneca shows Vaxzevaria vaccine, administered in India as Covishield, increased immune response to Beta, Delta, Alpha, Gamma variants after third dose.

No trial data on 3 shots of Covaxin, as precaution dose begins from next Monday

Trial on third Covaxin shot ongoing, results to be out soon, says Bharat Biotech. ICMR officials say 9-month interval based on studies that show antibodies last 6-13 months.

Govt says no Covaxin supply issue: 5 cr doses with states, 10 cr more coming in next 2 months

Only Covaxin will be used for vaccinating an estimated 7.4 crore 15-18-year-olds, so finding a slot for the first shot of the indigenous vaccine could get more difficult.

Booster dose of Covishield can increase antibody levels against Omicron, Oxford study says

Antibody levels against Omicron were higher in people who had taken a 3rd Covishield dose than in people who’d had other Covid variants, found a preprint study by Oxford researchers.

Covishield protection wanes after three months, Lancet study finds

The findings drawn from datasets in Brazil and Scotland suggest that booster programmes are needed in those vaccinated with AstraZeneca Covid vaccine, known as Covishield in India.The findings drawn from datasets in Brazil and Scotland suggest that booster programmes are needed in those vaccinated with AstraZeneca Covid vaccine, known as Covishield in India.

India considers ‘mix and match’ for Covid booster shots as calls for third dose grow

No decision has been taken yet on whether booster shots will be given, even as healthcare workers who got fully vaccinated in February near 10 months of vaccination.

ICMR study pushes for Covishield booster doses, says Delta derivatives could reduce efficacy

The study, however, says vaccines will continue to provide sufficient protection against the severity of the disease and fatality, based on breakthrough infections data they analysed.

ZyCov-D supplies to begin soon but may not be part of national vaccine programme right away

With Omicron on the prowl and decision pending on vaccinating children, government may wait before using the one crore doses of ZyCoV-D, the only vaccine licensed for use in minors

Covaxin, Covishield effectiveness highest when gap between doses is 6-8 weeks, ICMR study finds

Covishield is administered in India at an interval of 12-16 weeks, and Covaxin at 4-6 weeks. Study, yet to be peer-reviewed, also says vaccines are effective against Delta and other variants.

On Camera

Festive seasons align with the rollout of GST 2.0. Citizens to get more money in hand

The new norm marks a decisive shift from the earlier complex system that created friction for households and small businesses alike.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

30 civilians killed as Pakistan Air Force strikes Khyber Pakhtunkhwa village with China-made bombs

While Pakistani authorities have not clarified what intended target was, the incident adds to a troubling pattern of PAF strikes killing civilians, including women and children.

India doesn’t give walkovers to Pakistan in war. Here’s why it shouldn’t do it in cricket either

Many really smart people now share the position that playing cricket with Pakistan is politically, strategically and morally wrong. It is just a poor appreciation of competitive sport.